Standard Biotools (LAB) Net Income Growth (1y) (2011 - 2026)
Standard Biotools (LAB) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 75.09% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 12.92% |
| 10 | Standard Biotools | 254.42 Mn | -222.29 Mn | 10.54 Mn | 20.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66.85% |
| Mar 31, 2026 | 5,420.84% |
| Dec 31, 2025 | 178.01% |
| Sep 30, 2025 | 40.17% |
| Jun 30, 2025 | 22.14% |
| Mar 31, 2025 | 91.71% |
| Dec 31, 2024 | -148.84% |
| Sep 30, 2024 | 76.15% |
| Jun 30, 2024 | -18.99% |
| Mar 31, 2024 | -90.76% |
| Dec 31, 2023 | -90.78% |
| Sep 30, 2023 | 28.47% |
| Jun 30, 2023 | 73.19% |
| Mar 31, 2023 | 77.92% |
| Sep 30, 2022 | 40.93% |
| Jun 30, 2022 | -76.77% |
| Mar 31, 2022 | -305.96% |
| Sep 30, 2021 | -724.51% |
| Jun 30, 2021 | -176.24% |
| Mar 31, 2021 | -17.74% |